Name: 美國藥商對500種藥品提價 (Drugmakers in U.S. hike prices on 500 drugs)
Uploaded: 2021-01-05T21:00:14.000Z
Duration: 1 min 40 s

情態助動詞 B1

Taking Abbvie's drug, Humira may face higher prices this year.

服用Abbvie的藥物，Humira今年可能面臨更高的價格。

Healthcare Research Firm 46 Brooklyn says Abbvie raised prices on around 40 drugs, including a 7.4% hike on Humira, the world's top selling drugs.

醫療保健研究公司46布魯克林表示，Abbvie提高了約40種藥物的價格，其中包括全球最暢銷藥物Humira的價格上漲7.4%。

It's one of the more than 500 drugs in the U.

這是美國500多種藥物中的一種。

S that 46 Brooklyn says, kicked off 2021 with higher list prices.

S，布魯克林46號說，2021年開端，上市價錢較高。

It says nearly all the increases were below 10%.

它說幾乎所有的漲幅都在10%以下。

The median hike was down slightly from last year at 4.8%.

漲幅中位數較去年略有下降，為4.8%。

Bristol Myers raised prices on roughly a dozen drugs, including the price of its blood thinner eloquence by 6% and cancer drug Revlimid by 4.5%.

布里斯托爾邁爾斯提高了大約十幾種藥物的價格，其中包括其血液稀釋劑eloquence價格提高6%，癌症藥物Revlimid價格提高4.5%。

It said it on Lee raised prices on drugs with ongoing clinical research.

它說，它對李提高了正在進行臨床研究的藥物的價格。

It expects net prices to fall this year after factoring and rebates and other discounts.

該公司預計，在保理和返利等折扣後，今年的淨價將下降。

Last week, Reuters reported that Pfizer plans to raise prices on more than 60 drugs by between half percent and 5%.

上週，路透社報道稱，輝瑞公司計劃將60多種藥品的價格提高一半至5%。

The industry's price hikes come as the pandemic has reduced doctor visits and demand for some drugs.

業內人士表示，由於疫情減少了醫生的診療量，對一些藥品的需求也減少了，所以才會出現漲價的情況。

Drugmakers Air also fighting the Trump Administration's price cutting rules that would reduce the industry's profitability.

製藥商空也在對抗特朗普政府的降價規則，這將降低行業的盈利能力。

Since 2015, drug price increases have slowed substantially.

2015年以來，藥品價格漲幅大幅放緩。

But 46 Brooklyn says the average cost per branded drug is still inching upwards.

但46布魯克林表示，每個品牌藥的平均成本仍在寸步難行。

 It notes pharmaceutical manufacturers air cycling out cheaper brands that treat large populations, replacing them with pricier brands designed to treat smaller populations. 

它注意到，製藥商在空氣中循環出治療大量人口的廉價品牌，取而代之的是設計用於治療較小人口的昂貴品牌。